The bill narrows Exchange plan benefits to exclude elective abortion and certain gender‑transition services for minors—likely reducing some insurer costs and simplifying plan design while substantially limiting access to reproductive and gender‑affirming care and shifting costs and administrative burdens onto patients, safety‑net programs, and state systems.
Some Exchange enrollees may face lower premiums or reduced plan costs because the bill bars coverage of elective abortions and certain gender-transition procedures for minors, reducing insurers' benefit exposure.
The bill clarifies which benefits are allowed on Exchange plans, simplifying plan design, compliance, and consumer comparability for Exchanges, insurers, and state officials.
Women and pregnant people buying Exchange plans may lose insurance coverage for abortions beyond life‑threatening circumstances, leading to out-of-pocket costs, delayed care, and potential worsening of health outcomes.
Transgender minors will be unable to obtain Exchange‑covered puberty blockers, hormones, or surgeries, creating financial barriers to gender-affirming care and increasing health and mental‑health risks for transgender youth.
Coverage for treatment of complications from prior gender‑transition interventions may be ambiguous on Exchange plans, risking delayed or denied medically necessary care for affected patients.
Based on analysis of 2 sections of legislative text.
Prevents ACA Exchanges from offering plans that cover abortion (except to save life or after rape/incest) and bans coverage of gender-transition procedures for minors.
Prohibits Affordable Care Act Exchanges from offering any marketplace health plan that covers abortion (except to save the pregnant person’s life or when pregnancy resulted from rape or incest) and from offering coverage of gender-transition procedures for people under 18. The measure defines covered gender-transition procedures to include puberty blockers, cross-sex hormones, and sex-change surgeries, while allowing narrow medical exceptions for treatment of complications and for procedures needed to prevent imminent death or major bodily-function impairment. The changes apply to plan years beginning on or after January 1, 2026.
Introduced October 15, 2025 by Joshua David Hawley · Last progress October 15, 2025